Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tropical Diesel CBG is a cannabis-derived product, typically marketed as a high-cannabigerol (CBG) hemp concentrate or flower, infused with a specific Tropical Diesel terpene profile. Cannabigerol, often termed the mother cannabinoid, is a non-psychoactive compound that serves as the chemical precursor to major cannabinoids such as THC and CBD. It exerts its biological effects by interacting with the endocannabinoid system, primarily acting as a competitive antagonist at the Cannabinoid receptor 1 (CB1) and a partial agonist at the Cannabinoid receptor 2 (CB2). Beyond the endocannabinoid system, CBG demonstrates affinity for the 5-HT1A serotonin receptor as an antagonist and the alpha-2 adrenergic receptor as an agonist. The Tropical Diesel component refers to a proprietary blend of terpenes—typically including caryophyllene and limonene—that provide a citrusy, fuel-like aroma and may modulate the cannabinoid's effects through the entourage effect. This product is primarily used by consumers seeking potential relief from inflammation, pain, and anxiety without the intoxicating effects associated with THC.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tropical Diesel CBG.